Replimune

REPL NASDAQ
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $0 $0 $0 $0
Gross Profit -655 -700 -700 -621
EBITDA -57,918 -54,106 -64,143 -53,260
EBIT -58,623 -54,781 -64,797 -53,881
Net Income -55,075 -51,120 -60,044 -49,555
Net Change In Cash 0 0 0 0
Cost of Revenue -40,122
Free Cash Flow -47,906 -48,842 -45,344 -49,037
Cash 74,457 97,672 75,996 106,481
Basic Shares 61,415 66,645 66,582 66,367

Annual Financials

Values in thousands 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Revenue $0 $0 $0 $0
Gross Profit -2,655 -2,447 -4,575 -4,139
EBITDA -234,038 -177,395 -114,056 -76,102
EBIT -236,693 -179,842 -116,203 -77,813
Net Income -215,794 -174,284 -118,036 -80,870
Net Change In Cash 0 0 0 0
Cost of Revenue 122,297
Free Cash Flow -191,129 -130,320 -84,516 -63,781
Cash 74,457 146,590 105,948 182,518
Basic Shares 66,569 58,213 52,212 46,248

Earnings Calls

Quarter EPS
2024-03-31 -$0.82
2023-12-31 -$0.77
2023-09-30 -$0.90
2023-06-30 -$0.75